Pulse Biosciences Inc EBITDA
Что обозначает EBITDA в Pulse Biosciences Inc?
EBITDA Pulse Biosciences Inc является -$38.55
Какое определение для EBITDA?
EBITDA - это прибыль компании до вычета процентов, налогов, обесценивания и амортизации, а также является бухгалтерской мерой, рассчитанной с использованием чистой прибыли компании до вычета процентных расходов, налогов, обесценивания и амортизации в качестве показателя текущей операционной прибыли компании.
Although EBITDA is not a financial measure recognized in generally accepted accounting principles, it is widely used in many areas of finance when assessing the performance of a company, such as securities analysis. It is intended to allow a comparison of profitability between different companies, by discounting the effects of interest payments from different forms of financing (by ignoring interest payments), political jurisdictions (by ignoring tax), collections of assets (by ignoring depreciation of assets), and different takeover histories (by ignoring amortization often stemming from goodwill). EBITDA is a financial measurement of cash flow from operations that is widely used in mergers and acquisitions of small businesses and businesses in the middle market. It is not unusual for adjustments to be made to EBITDA to normalize the measurement allowing buyers to compare the performance of one business to another.
EBITDA компаний в Health Care сектор на NASDAQ по сравнению с Pulse Biosciences Inc
Что делает Pulse Biosciences Inc?
pulse biosciences, inc. is a clinical stage electroceutical, an electrical energy based therapeutic, company pursuing commercial applications of its proprietary nano-pulse stimulation (nps) technology. nps is a non-thermal, drug-free energy-based technology that can stimulate unique behaviors in cells by applying ultra-short nanosecond (billionths of a second) electrical pulses that affect the cell membrane and intracellular structures. these cell effects influence cell regulation functions and can lead to unique immune system responses. pulse biosciences is investigating a variety of applications for its nps technology that exploits its unique biologic effect, including immuno-oncology and dermatology. pulse biosciences, inc. (plse, nasdaq) corporate headquarters is located in hayward, ca. ~ our mission ~ to build a viable company that designs, produces, and commercializes nano-pulse technology to improve and extend the lives of patients to solve the needs of patients, physicians, and
Компании с ebitda похож на Pulse Biosciences Inc
- U&I Plc имеет EBITDA из -£38.66
- Fujian Blue Hat Interactive Entertainment Technology имеет EBITDA из -$38.66
- Inseego имеет EBITDA из -$38.61
- Risecomm имеет EBITDA из -¥38.58
- Boill Healthcare имеет EBITDA из -HKD$38.55
- Scorpio Bulkers Inc имеет EBITDA из -$38.55
- Pulse Biosciences Inc имеет EBITDA из -$38.55
- 51 Credit Card имеет EBITDA из -¥38.46
- Uxin Ltd имеет EBITDA из -¥38.45
- Sonendo имеет EBITDA из -$38.44
- Cerus имеет EBITDA из -$38.42
- China Brilliant Global имеет EBITDA из -HKD$38.41
- Danimer Scientific имеет EBITDA из -$38.37